Why MRD is a hot topic in CLL and how it should be used
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
How to explain the 'watch-and-wait' period to a CLL patient?
The road to individualized treatment for CLL
CAR T-cells and fast cars